Navigating Cell & Gene Therapy (CGT) Financial Models – Employer & Practitioner Insights

Event Image

Navigating Cell & Gene Therapy (CGT) Financial Models – Employer & Practitioner Insights



Dial-in Instructions:
The registration confirmation email will contain links to participate virtually. All registrants will receive communications from info@mbgh.org prior to the event.
When:  Oct 21, 2025 from 12:30 PM to 02:00 PM (CT)

Agenda 

Event Description

Fireside Chat. This webinar will provide a discussion of the current cell and gene therapy financial models, coverage, emerging research, and a real-world example of one model in practice today. Attendees will gain a deeper understanding of how the various cost management models can impact CGT spend, and how employers can leverage them moving forward.

Leading experts will share overall perspectives on what’s new and what’s different, including:

  • New innovations and what’s coming down the pipeline.
  • Update on finance and coverage solutions and cost management models that can impact spend.
  • Where employers are headed and where efforts need to focus in the future.
  • Ways MBGH and other leading stakeholders can support employers.


This program is only available virtually.

Speakers



  • R'Kes Starling, RPH CEO Bowtie Therapeutic Benefits
  • Dan Dentzer Manager: Health & Wellness Benefits Strategy United Airlines
  • Jason Duhon Director of Total Rewards Caterpillar, Inc.
  • Kirby Eng, R.Ph Chief Clinical Officer OutcomeRx
  • Sherri Samuels-Fuerst VP, Advisor Total Rewards Sargento Cheese
  • Erin Lopata, PharmD VP, Director Precision AQ
  • Carole Mendoza VP, Global Benefits & Employee Mobility HP Inc.
  • Tom Sondergeld Managing Partner TS Consulting Group

Registration Fees

  • Members $0
  • Employer Non-Members $50
  • Other Non-Members $150

Register